Journal of the European Academy of Dermatology and Venereology : JEADV
scRNA-Seq reveals anti-lymphoma immune responses in mogamulizumab-associated skin eruptions.
Shannon Meledathu, Agata Kurowski, Malini P Naidu, Jonas Adalsteinsson, Shane A Meehan, Natalia Alkon, Lauren R Port, Sumanth Chennareddy, Emry R Cohenour, Grace Christensen, Jonah Shulman, Nicholas Gulati, Constanze Jonak, Patrick M Brunner
Published: 202510.1111/jdv.70154
Abstract
BACKGROUND: Mogamulizumab is an anti-CCR4 therapeutic antibody approved for relapsed or refractory mycosis fungoides, Sézary syndrome and adult T-cell leukaemia/lymphoma. During treatment, a subset of patients develops a mogamulizumab-associated drug…
Preview only. Read the full abstract at the source